Skip to main content

Table 5 Univariate analysis of mortality in elderly bedridden patients with hip fracture and lower respiratory tract infection

From: Elderly patients with concurrent hip fracture and lower respiratory tract infection: the pathogens and prognosis over different bedridden periods

Number

Variable

OR (95% CI)

P

1

Age

1.10 (1.01–1.20)

0.025

2

Bedridden time after hip fracture

1–12 month, 1.37 (0.21–8.80)

0.003

Reference, < 1 month

> 12 month, 8.60 (2.18–33.9)

3

Indwelling nasal feeding

9.16 (2.70, 31.1)

< 0.001

4

Number of hospitalizations in the past year

1.47 (1.09–1.98)

0.011

5

Days of hospitalization

1.04 (1.01–1.08)

0.027

6

Serum albumin level

0.79 (0.68–0.90)

< 0.001

7

Infection with drug-resistant fungus

7.55 (2.19, 26.1)

0.001

8

Infection with drug-resistant bacteria

10.7 (3.22–35.4)

< 0.001

9

Third-generation cephalosporins (without enzyme inhibitors)

3.17 (1.09–9.24)

0.034

10

Antibiotics need to be upgraded

7.68 (2.41–24.4)

< 0.001

11

Numbers of antibiotics upgrade M

2.27 (1.43–3.61)

< 0.001

12

Use of antifungal drugs

5.50 (1.81–16.7)

0.003

13

Use of glucocorticoids during antibiotic therapy

Oral, 5.06 (0.41–62.1)

< 0.001

Reference, not used

Intravenous, 81 (8.96–732)

14

Use of glucocorticoids

30.4 (6.81–135)

< 0.001

15

Parenteral nutrition support

8.43 (2.70–26.4)

< 0.001

16

Tracheal intubation or tracheotomy

4.86 (1.15–20.5)

0.031